Integra Lifesciences Holdings Stock Performance
| IART Stock | USD 11.05 0.27 2.50% |
The company retains a Market Volatility (i.e., Beta) of 2.29, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Integra LifeSciences will likely underperform. At this point, Integra LifeSciences has a negative expected return of -0.0256%. Please make sure to check out Integra LifeSciences' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Integra LifeSciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Integra LifeSciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Integra LifeSciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (3.41) | Five Day Return (2.36) | Year To Date Return (10.24) | Ten Year Return (64.76) | All Time Return 133.08 |
Last Split Factor 2:1 | Last Split Date 2017-01-04 |
1 | Disposition of 472 shares by Robert Davis of Integra LifeSciences at 23.95 subject to Rule 16b-3 | 11/21/2025 |
2 | Q3 Earnings Outperformers Teleflex And The Rest Of The Surgical Equipment Consumables - Specialty Stocks | 12/10/2025 |
3 | Integra receives accelerated federal permitting schedule for DeLamar project | 01/13/2026 |
4 | Integra Resources Is Up 6.4 percent After BLM Sets NEPA Timeline for DeLamar Project | 01/14/2026 |
5 | Beedie Capital Holdings Ltd. Announces Filing of Updated Early Warning Report in Relation to Integra Resources | 01/16/2026 |
6 | Aug Decliners Is Integra LifeSciences Holdings Corporation a cyclical or defensive stock - July 2025 Retail Weekly Hot Stock Watchlists - baoquankhu1.vn | 01/20/2026 |
7 | Intracranial Pressure Monitoring Market to Reach USD 3.46 Billion by 2033, Driven by Increasing Prevalence of Neurological Disorders Advancements in Non-Invasiv... | 01/22/2026 |
8 | INTEGRA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 GOLD PRODUCTION RESULTS FROM FLORIDA CANYON MINE, ACHIEVING PRODUCTION GUIDANCE AND SIGNIFICANT CAPITAL REIN... | 01/26/2026 |
9 | Is It Time To Consider Buying Integra LifeSciences Holdings Corporation | 01/29/2026 |
10 | Integra Resources Shares Gap Up Heres Why | 02/03/2026 |
| Begin Period Cash Flow | 276.4 M | |
| Total Cashflows From Investing Activities | -390.8 M |
Integra LifeSciences Relative Risk vs. Return Landscape
If you would invest 1,122 in Integra LifeSciences Holdings on November 6, 2025 and sell it today you would lose (44.00) from holding Integra LifeSciences Holdings or give up 3.92% of portfolio value over 90 days. Integra LifeSciences Holdings is currently does not generate positive expected returns and assumes 2.91% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Integra, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Integra LifeSciences Target Price Odds to finish over Current Price
The tendency of Integra Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 11.05 | 90 days | 11.05 | more than 94.0 |
Based on a normal probability distribution, the odds of Integra LifeSciences to move above the current price in 90 days from now is more than 94.0 (This Integra LifeSciences Holdings probability density function shows the probability of Integra Stock to fall within a particular range of prices over 90 days) .
Integra LifeSciences Price Density |
| Price |
Predictive Modules for Integra LifeSciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Integra LifeSciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Integra LifeSciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Integra LifeSciences is not an exception. The market had few large corrections towards the Integra LifeSciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Integra LifeSciences Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Integra LifeSciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.56 | |
β | Beta against Dow Jones | 2.29 | |
σ | Overall volatility | 0.90 | |
Ir | Information ratio | -0.13 |
Integra LifeSciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Integra LifeSciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Integra LifeSciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Integra LifeSciences generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 1.61 B. Net Loss for the year was (6.94 M) with profit before overhead, payroll, taxes, and interest of 944.73 M. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Integra Resources Shares Gap Up Heres Why |
Integra LifeSciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Integra Stock often depends not only on the future outlook of the current and potential Integra LifeSciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Integra LifeSciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 77 M | |
| Cash And Short Term Investments | 273.6 M |
Integra LifeSciences Fundamentals Growth
Integra Stock prices reflect investors' perceptions of the future prospects and financial health of Integra LifeSciences, and Integra LifeSciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integra Stock performance.
| Return On Equity | -0.39 | ||||
| Return On Asset | 0.0261 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 2.61 B | ||||
| Shares Outstanding | 77.89 M | ||||
| Price To Earning | 26.94 X | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 0.53 X | ||||
| Revenue | 1.61 B | ||||
| Gross Profit | 944.73 M | ||||
| EBITDA | 193.29 M | ||||
| Net Income | (6.94 M) | ||||
| Cash And Equivalents | 451.52 M | ||||
| Cash Per Share | 5.41 X | ||||
| Total Debt | 1.98 B | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 3.85 X | ||||
| Book Value Per Share | 13.33 X | ||||
| Cash Flow From Operations | 129.38 M | ||||
| Earnings Per Share | (6.47) X | ||||
| Market Capitalization | 869.48 M | ||||
| Total Asset | 4.04 B | ||||
| Retained Earnings | 939.91 M | ||||
| Working Capital | 159.56 M | ||||
| Current Asset | 438.5 M | ||||
| Current Liabilities | 139.13 M | ||||
About Integra LifeSciences Performance
Assessing Integra LifeSciences' fundamental ratios provides investors with valuable insights into Integra LifeSciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Integra LifeSciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 193.50 | 170.45 | |
| Return On Capital Employed | 0.01 | 0.01 |
Things to note about Integra LifeSciences performance evaluation
Checking the ongoing alerts about Integra LifeSciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Integra LifeSciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integra LifeSciences generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 1.61 B. Net Loss for the year was (6.94 M) with profit before overhead, payroll, taxes, and interest of 944.73 M. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Integra Resources Shares Gap Up Heres Why |
- Analyzing Integra LifeSciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integra LifeSciences' stock is overvalued or undervalued compared to its peers.
- Examining Integra LifeSciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integra LifeSciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integra LifeSciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integra LifeSciences' stock. These opinions can provide insight into Integra LifeSciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.